Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) Debt Ratio (2018 - 2025)

Historic Debt Ratio for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to 0.31.

  • Takeda Pharmaceutical's Debt Ratio fell 1042.06% to 0.31 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.31, marking a year-over-year decrease of 1042.06%. This contributed to the annual value of 0.32 for FY2025, which is 110.93% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Debt Ratio stood at 0.31 for Q4 2025, which was down 1042.06% from 0.34 recorded in Q3 2025.
  • Takeda Pharmaceutical's Debt Ratio's 5-year high stood at 0.39 during Q2 2021, with a 5-year trough of 0.31 in Q1 2023.
  • For the 5-year period, Takeda Pharmaceutical's Debt Ratio averaged around 0.34, with its median value being 0.34 (2025).
  • As far as peak fluctuations go, Takeda Pharmaceutical's Debt Ratio plummeted by 1329.21% in 2021, and later skyrocketed by 689.04% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Debt Ratio (Quarter) stood at 0.37 in 2021, then fell by 11.48% to 0.33 in 2022, then increased by 3.92% to 0.34 in 2023, then increased by 3.1% to 0.35 in 2024, then dropped by 10.42% to 0.31 in 2025.
  • Its Debt Ratio stands at 0.31 for Q4 2025, versus 0.34 for Q3 2025 and 0.33 for Q2 2025.